Virtual Event | December 11, 2024

Unlocking The Full Potential Of AAV-Mediated Gene Delivery

Source: Cell & Gene

Despite significant advances, challenges remain in optimizing AAV-based treatments for broader clinical application. Cell & Gene Live host, Erin Harris, welcomed two leading experts in the field: David Dismuke, PhD, Chief Technical Officer, Forge Biologics, and Nina Hunter, PhD, Vice President of Clinical Development at REGENXBIO.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)